#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4707860	B	Inverse agonist activity at APC-labeled RORgammat LBD (unknown origin) assessed as inhibition of europium-labeled co-activator SRC1 recruitment incubated for 1 hr by FRET assay	Homo sapiens	28	ALA4706491	single protein format	Scientific Literature
2.	ALA4707861	B	Inverse agonist activity at APC-labeled RORgammat LBD (unknown origin) assessed as inhibition of europium-labeled co-activator SRC1 recruitment incubated for 1 hr by FRET assay relative to control	Homo sapiens	27	ALA4706491	single protein format	Scientific Literature
3.	ALA4707864	B	Inverse agonist activity at RORgammat in mouse CD4+ T cells assessed as inhibition of differentiation into Th17 cells by measuring IL-17 production by flow cytometry	Mus musculus	2	ALA4706491	cell-based format	Scientific Literature
4.	ALA4707865	B	Inverse agonist activity at RORgammat in mouse CD4+ T cells assessed as inhibition of differentiation into Th17 cells by measuring IL-17 production by flow cytometry relative to control	Mus musculus	2	ALA4706491	cell-based format	Scientific Literature
5.	ALA4707866	A	Half life in CD-1 mouse liver microsomes at 1 uM measured up to 60 mins in presence of NADPH by LC-MS/MS analysis	Mus musculus	2	ALA4706491	microsome format	Scientific Literature
6.	ALA4707867	A	Intrinsic clearance in CD-1 mouse liver microsomes assessed per mg protein at 1 uM measured up to 60 mins in presence of NADPH by LC-MS/MS analysis	Mus musculus	2	ALA4706491	microsome format	Scientific Literature
7.	ALA4707868	A	Intrinsic clearance in CD-1 mouse liver at 1 uM measured up to 60 mins in presence of NADPH by LC-MS/MS analysis	Mus musculus	2	ALA4706491	tissue-based format	Scientific Literature
8.	ALA4707869	A	Metabolic stability in CD-1 mouse liver microsomes assessed as parent compound remaining at 1 uM measured at 60 mins in presence of NADPH by LC-MS/MS analysis	Mus musculus	1	ALA4706491	microsome format	Scientific Literature
9.	ALA4707870	A	Half life in CD-1 mouse at 50 mg/kg, po	Mus musculus	1	ALA4706491	organism-based format	Scientific Literature
10.	ALA4707871	A	Tmax in CD-1 mouse at 50 mg/kg, po	Mus musculus	1	ALA4706491	organism-based format	Scientific Literature
11.	ALA4707872	A	Cmax in CD-1 mouse at 50 mg/kg, po	Mus musculus	1	ALA4706491	organism-based format	Scientific Literature
12.	ALA4707873	A	AUC (0 to t) in CD-1 mouse at 50 mg/kg, po	Mus musculus	1	ALA4706491	organism-based format	Scientific Literature
13.	ALA4707874	F	Antiinflammatory activity against imiquimod-induced psoriasis in ip dosed BALB/c mouse model assessed as reduction in clinical severity administered once daily for 12 days	Mus musculus	1	ALA4706491	organism-based format	Scientific Literature
14.	ALA4707875	F	Antiinflammatory activity against imiquimod-induced psoriasis BALB/c mouse model assessed as reduction in ear thickness at 10 to 50 mg/kg, ip administered once daily for 12 days by hematoxylin and eosin staining based analysis	Mus musculus	1	ALA4706491	organism-based format	Scientific Literature
15.	ALA4707877	F	Antiinflammatory activity against imiquimod-induced psoriasis BALB/c mouse model assessed as body weight loss at 50 mg/kg, ip administered once daily for 12 days (Rvb = 19.94 +/- 0.78 g)	Mus musculus	1	ALA4706491	organism-based format	Scientific Literature
16.	ALA4707878	F	Antiinflammatory activity against imiquimod-induced psoriasis BALB/c mouse model assessed as body weight loss at 10 mg/kg, ip administered once daily for 12 days (Rvb = 19 +/- 0.64 g)	Mus musculus	1	ALA4706491	organism-based format	Scientific Literature
17.	ALA4707879	F	Antiinflammatory activity against imiquimod-induced psoriasis BALB/c mouse model assessed as body weight loss at 2 mg/kg, ip administered once daily for 12 days (Rvb = 19.89 +/- 1.16 g)	Mus musculus	1	ALA4706491	organism-based format	Scientific Literature
18.	ALA4707880	F	Antiinflammatory activity against imiquimod-induced psoriasis BALB/c mouse model assessed as body weight loss at 0.4 mg/kg, ip administered once daily for 12 days (Rvb = 19.71 +/- 0.92 g)	Mus musculus	1	ALA4706491	organism-based format	Scientific Literature
19.	ALA4707882	F	Antiinflammatory activity against imiquimod-induced psoriasis BALB/c mouse model assessed as inhibition of back skin erythema at 0.4 mg/kg, ip administered once daily for 12 days	Mus musculus	1	ALA4706491	organism-based format	Scientific Literature
20.	ALA4707883	F	Antiinflammatory activity against imiquimod-induced psoriasis BALB/c mouse model assessed as inhibition of back skin scaling at 0.4 mg/kg, ip administered once daily for 12 days	Mus musculus	1	ALA4706491	organism-based format	Scientific Literature